These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 18681351)
1. Progressive paresthesia and weakness after intrathecal chemotherapy. Marshall R; Gupta ND; Palacios E; Neitzschman HR J La State Med Soc; 2008; 160(2):92-4. PubMed ID: 18681351 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055 [TBL] [Abstract][Full Text] [Related]
3. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284 [TBL] [Abstract][Full Text] [Related]
4. Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients. Gill S; Lane SW; Crawford J; Cull G; Joske D; Marlton P; Mollee PN; Prince HM; Seymour JF Ann Hematol; 2008 Sep; 87(9):727-34. PubMed ID: 18401583 [TBL] [Abstract][Full Text] [Related]
5. [An adult case of precursor B cell lymphoblastic lymphoma extending from right neck to upper cervical spinal region]. Nishihara M; Kudo H; Mizuno I; Taomoto K; Kohmura E No Shinkei Geka; 2005 Nov; 33(11):1107-11. PubMed ID: 16277225 [TBL] [Abstract][Full Text] [Related]
6. Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia. O'Brien S; Thomas DA; Ravandi F; Faderl S; Pierce S; Kantarjian H Cancer; 2008 Oct; 113(8):2097-101. PubMed ID: 18720356 [TBL] [Abstract][Full Text] [Related]
7. Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia: a retrospective multicenter study. Buyukasik Y; Acar K; Kelkitli E; Uz B; Serefhanoglu S; Ozdemir E; Pamukcuoglu M; Atay H; Bektas O; Sucak GT; Turgut M; Aksu S; Yagci M; Sayınalp N; Ozcebe OI; Goker H; Haznedaroglu IC Acta Haematol; 2013; 130(3):199-205. PubMed ID: 23797290 [TBL] [Abstract][Full Text] [Related]
8. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. Kantarjian HM; O'Brien S; Smith TL; Cortes J; Giles FJ; Beran M; Pierce S; Huh Y; Andreeff M; Koller C; Ha CS; Keating MJ; Murphy S; Freireich EJ J Clin Oncol; 2000 Feb; 18(3):547-61. PubMed ID: 10653870 [TBL] [Abstract][Full Text] [Related]
9. The effect of the Hyper-CVAD chemotherapy regimen on fertility and ovarian function. Seshadri T; Hourigan MJ; Wolf M; Mollee PN; Seymour JF Leuk Res; 2006 Apr; 30(4):483-5. PubMed ID: 16171861 [TBL] [Abstract][Full Text] [Related]
10. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Jabbour E; O'Brien S; Kantarjian H; Garcia-Manero G; Ferrajoli A; Ravandi F; Cabanillas M; Thomas DA Blood; 2007 Apr; 109(8):3214-8. PubMed ID: 17209054 [TBL] [Abstract][Full Text] [Related]
11. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma. Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182 [TBL] [Abstract][Full Text] [Related]
12. [A clinical report on modified Hyper-CVAD regimen in patients with lymphoblastic lymphoma]. Shi W; Shi YK; He XH; Zhou SY; Dong M; Zhang CG; Yang JL; Liu P; Qin Y; Yang S; Gui L Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):978-81. PubMed ID: 20646648 [TBL] [Abstract][Full Text] [Related]
13. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Büyükçelik A; Yalçin B; Utkan G; Doruk H Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922 [No Abstract] [Full Text] [Related]
14. Cytomegalovirus retinitis during chemotherapy with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone. Libby E; Movva S; Quintana D; Abdul-Jaleel M; Das A J Clin Oncol; 2010 Nov; 28(32):e661-2. PubMed ID: 20855824 [No Abstract] [Full Text] [Related]
15. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia. Yegin ZA; Aki S; Sucak G; Yagci M Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309 [No Abstract] [Full Text] [Related]